Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Indacaterol/mometasone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atectura Breezhaler 125microg/260microg inhalation pdr caps
0302000X0BBACAC
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 99 |
|
Atectura Breezhaler 125microg/127.5microg pdr caps
0302000X0BBABAB
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 55 |
|
Indacaterol 125microg/Mometasone 260microg/dose pdr caps
0302000X0AAACAC
|
Indacaterol/mometasone | Indacaterol/mometasone | Respiratory System | 11 |
|
Atectura Breezhaler 125microg/62.5microg inhalation pdr caps
0302000X0BBAAAA
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 5 |
|
Indacaterol 125microg/Mometasone 127.5microg/dose pdr caps
0302000X0AAABAB
|
Indacaterol/mometasone | Indacaterol/mometasone | Respiratory System | 4 |
|
Indacaterol 125microg/Mometasone 62.5microg/dose pdr caps
0302000X0AAAAAA
|
Indacaterol/mometasone | Indacaterol/mometasone | Respiratory System | 2 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.